IA-2 antibodies – a sensitive marker of IDDM with clinical onset in childhood and adolescence
Authors:
K. Savola, E. Bonifacio, E. Sabbah, P. Kulmala, P. Vähäsalo, J. Karjalainen, E. Tuomilehto-Wolf, J. Meriläinen, H. K. Åkerblom, M. Knip, Childhood Diabetes Finland Study Group
IA-2 antibodies – a sensitive marker of IDDM with clinical onset in childhood and adolescence
Authors
K. Savola E. Bonifacio E. Sabbah P. Kulmala P. Vähäsalo J. Karjalainen E. Tuomilehto-Wolf J. Meriläinen H. K. Åkerblom M. Knip Childhood Diabetes Finland Study Group
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.